Assignee
MACROGENICS INC
US·86 granted patents·65 pending applications·1,894 citations·filing 2003–2025
Top patents by PatentIndex Score
151 records- 0198US8003774B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2008·Granted Aug 23, 2011·96 cites·52 claims
- 0298US7355008B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Apr 8, 2008·361 cites·22 claims
- 0397US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0497US8044180B2FcγRIIB specific antibodies and methods of use thereofMACROGENICS INC·Filed 2008·Granted Oct 25, 2011·52 cites·40 claims
- 0597US7960512B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Jun 14, 2011·161 cites·11 claims
- 0697US7786270B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2007·Granted Aug 31, 2010·55 cites·5 claims
- 0797US7521542B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2005·Granted Apr 21, 2009·105 cites·8 claims
- 0897US7425619B2FcγRIIB specific antibodies and methods of use thereofMACROGENICS INC·Filed 2003·Granted Sep 16, 2008·156 cites·40 claims
- 0996US10131713B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Nov 20, 2018·10 cites·20 claims
- 1096US7351803B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2003·Granted Apr 1, 2008·78 cites·18 claims
- 1196US7112439B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2004·Granted Sep 26, 2006·78 cites·27 claims
- 1295US11623959B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2020·Granted Apr 11, 2023·6 cites·23 claims
- 1395US10711069B2Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibitingMACROGENICS INC·Filed 2017·Granted Jul 14, 2020·7 cites·16 claims
- 1495US10633440B2Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigensMACROGENICS INC·Filed 2015·Granted Apr 28, 2020·11 cites·18 claims
- 1595US10577422B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 3, 2020·19 cites·10 claims
- 1695US10160806B2Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereofMACROGENICS INC·Filed 2015·Granted Dec 25, 2018·18 cites·34 claims
- 1795US9896508B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2016·Granted Feb 20, 2018·8 cites·12 claims
- 1895US9469692B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Oct 18, 2016·8 cites·14 claims
- 1995US7718774B2TES7 and antibodies that bind theretoMACROGENICS INC·Filed 2007·Granted May 18, 2010·32 cites·22 claims
- 2094US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 2194US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 2294US9708408B2Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibitingMACROGENICS INC·Filed 2014·Granted Jul 18, 2017·9 cites·10 claims
- 2394US9243069B2HER2/neu-specific antibodies and methods of using the sameMACROGENICS INC·Filed 2014·Granted Jan 26, 2016·13 cites·9 claims
- 2494US7700100B2FcγRIIB fusion proteins and compositions thereofMACROGENICS INC·Filed 2004·Granted Apr 20, 2010·54 cites·4 claims
- 2594US7618628B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 17, 2009·22 cites·23 claims
- 2693US11858991B2LAG-3-binding molecules and methods of use thereofMACROGENICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·18 claims
- 2793US11111299B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2018·Granted Sep 7, 2021·3 cites·31 claims
- 2893US9441049B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Sep 13, 2016·10 cites·11 claims
- 2993US8951517B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2013·Granted Feb 10, 2015·19 cites·15 claims
- 3093US7572456B2Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereofMACROGENICS INC·Filed 2005·Granted Aug 11, 2009·21 cites·19 claims
- 3192US10150812B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2017·Granted Dec 11, 2018·9 cites·28 claims
- 3292US10093738B2Covalent diabodies and uses thereofMACROGENICS INC·Filed 2016·Granted Oct 9, 2018·7 cites·15 claims
- 3392US9695236B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2015·Granted Jul 4, 2017·11 cites·19 claims
- 3492US7838635B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 23, 2010·17 cites·19 claims
- 3592US7776328B2Antibodies that bind to EphA2 and methods of use thereofMACROGENICS INC·Filed 2009·Granted Aug 17, 2010·6 cites·28 claims
- 3691US11421031B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·22 claims
- 3791US11028183B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2018·Granted Jun 8, 2021·3 cites·38 claims
- 3891US9714296B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·7 cites·27 claims
- 3991US9487587B2Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 8, 2016·9 cites·14 claims
- 4090US9714295B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·6 cites·27 claims
- 4190US7632497B2Engineering Fc Antibody regions to confer effector functionMACROGENICS INC·Filed 2005·Granted Dec 15, 2009·217 cites·42 claims
- 4289US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 4389US11459394B2Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereofMACROGENICS INC·Filed 2018·Granted Oct 4, 2022·4 cites·8 claims
- 4489US11384149B2Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereofMACROGENICS INC·Filed 2019·Granted Jul 12, 2022·4 cites·13 claims
- 4589US10683364B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2017·Granted Jun 16, 2020·3 cites·20 claims
- 4689US8993730B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2013·Granted Mar 31, 2015·10 cites·33 claims
- 4789US7906327B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2006·Granted Mar 15, 2011·9 cites·22 claims
- 4889US2024409661A1Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 4988US11072653B2LAG-3-binding molecules and methods of use thereofMACROGENICS INC·Filed 2016·Granted Jul 27, 2021·4 cites·17 claims
- 5088US10954301B2Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 23, 2021·3 cites·8 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →